Literature DB >> 8215255

Cerebrospinal fluid inhibits Alzheimer beta-amyloid fibril formation in vitro.

T Wisniewski1, E Castano, J Ghiso, B Frangione.   

Abstract

Alzheimer's disease is characterized by the deposition of beta-protein (A beta) as amyloid. Recently, it was found that A beta is a normal component of serum and cerebrospinal fluid. Synthetic peptides homologous to A beta form amyloid-like fibrils spontaneously in water or physiological solutions. Using a peptide homologous to A beta 1-40, we find that fibril formation is inhibited by the presence of cerebrospinal fluid.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8215255     DOI: 10.1002/ana.410340422

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

1.  Cerebrospinal Fluid Proteins as Regulators of Beta-amyloid Aggregation and Toxicity.

Authors:  Kayla M Pate; Regina M Murphy
Journal:  Isr J Chem       Date:  2017-01-18       Impact factor: 3.333

2.  Cerebellar neurodegeneration in a new rat model of episodic hepatic encephalopathy.

Authors:  Teresa García-Lezana; Marc Oria; Jordi Romero-Giménez; Jordi Bové; Miquel Vila; Joan Genescà; Laia Chavarria; Juan Cordoba
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

3.  Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice.

Authors:  E M Sigurdsson; H Scholtzova; P D Mehta; B Frangione; T Wisniewski
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

4.  Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.

Authors:  T Wisniewski; E M Castaño; A Golabek; T Vogel; B Frangione
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

5.  Apolipoprotein J and Alzheimer's amyloid beta solubility.

Authors:  E Matsubara; C Soto; S Governale; B Frangione; J Ghiso
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

Review 6.  Unifying features of systemic and cerebral amyloidosis.

Authors:  J Ghiso; T Wisniewski; B Frangione
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

7.  Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.

Authors:  E M Castano; F Prelli; T Wisniewski; A Golabek; R A Kumar; C Soto; B Frangione
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

8.  Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans.

Authors:  C D Link
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

Review 9.  Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?

Authors:  Xinyi Li; Joel N Buxbaum
Journal:  Mol Neurodegener       Date:  2011-11-23       Impact factor: 14.195

10.  Highly potent soluble amyloid-β seeds in human Alzheimer brain but not cerebrospinal fluid.

Authors:  Sarah K Fritschi; Franziska Langer; Stephan A Kaeser; Luis F Maia; Erik Portelius; Dorothea Pinotsi; Clemens F Kaminski; David T Winkler; Walter Maetzler; Kathy Keyvani; Philipp Spitzer; Jens Wiltfang; Gabriele S Kaminski Schierle; Henrik Zetterberg; Matthias Staufenbiel; Mathias Jucker
Journal:  Brain       Date:  2014-09-10       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.